Stay updated on FG-4592 and Rosiglitazone Interaction Clinical Trial
Sign up to get notified when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.
Latest updates to the FG-4592 and Rosiglitazone Interaction Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label in the page footer updated from v3.2.0 to v3.3.2 as part of a platform update; no changes to study details or primary content.SummaryDifference0.1%
- Check27 days agoChange DetectedRemoved the government funding notice banner at the top of the page, reducing operational notices shown to users. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check49 days agoChange DetectedUI updates have changed the page layout, header, and styling, while the core study details such as title, conditions, eligibility criteria, and interventions remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check70 days agoChange Detected- Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.SummaryDifference7%
- Check77 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.2%
- Check92 days agoChange DetectedRevision updated to v3.0.2; the 'Back to Top' link was removed. No substantive changes to core content or key data were detected.SummaryDifference0.4%
Stay in the know with updates to FG-4592 and Rosiglitazone Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.